biotech
Pharmafocus wants to hear from you!
July 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, biotech, drugs, healthcare, pharma, pharmaceutical
We are always looking for new ways to improve the next issue of Pharmafocus, and now we’re planning a new …
GSK completes further high-profile staff acquisition
July 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Pfizer, biotech, drugs, pharma, pharmaceutical
Pfizer Senior Vice President of Medicinal Sciences, Tony Wood, has agreed to join GSK, as broken by FierceBiotech. The appointment …
Research may unlock statins cancer-fighting ability
July 17, 2017Research and Development, Sales and Marketing Keele University, biotech, drugs, pharma, pharmaceutical, statins
Many previous studies have shown that statins are able to have an impact on cancer cells but the results have …
What pharma should know about the European Unitary Patent in light of Brexit
July 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, UK, biotech, brexit, drugs, healthcare, pharma, pharmaceutical
The departure of the United Kingdom from the European Union, dubbed “Brexit,” has sparked significant economic global uncertainty. Two Brexit-related …
Pierre Fabre secures Italian distribution rights for Noventure’s Aprotecol
July 17, 2017Sales and Marketing Aprotecol, Noventure, Pierre Fabre, biotech, colic, drugs, healthcare, pharma, pharmacuetical
Noventure has allied with Pierre Fabre Pharma Italy in a partnership which will see the latter distribute the Spanish start-up’s …
20 million mosquitoes to be released to limit population
July 17, 2017Research and Development, Sales and Marketing Novartis, Verily, biotech, drugs, google, pharma, pharmaceutical
Releasing 20 million mosquitoes does not sound like the right way to go about reducing the overall population; however, the …
FDA refuses approval of Amgen osteoporosis drug
July 17, 2017Sales and Marketing Amgen, Evenity, Radial, UCB, biotech, drugs, osteoporosis, pharma, pharmaceutical
Amgen and its development partner UCB have announced that the FDA has issued a complete response letter for the biologics …
AstraZeneca’s Soriot Teva switch scotched
July 17, 2017Medical Communications, Sales and Marketing AstraZeneca, Soriot, Teva, biotech, drugs, pharma, pharmaceutical
The rumours, beginning with a report by Israeli newspaper Calcalist, had suggested that Pascal Soriot, CEO of AstraZeneca, appeared to …
UK government announces £86 million funding as tentative AAR step
July 14, 2017Medical Communications NHS, UK government, biotech, drugs, pharma, pharmaceutical
The UK government has revealed that it will apportion £86 million to help the assessment of new technologies and increase …
Not long after leaving GSK, Andrew Witty dips toes back into water
July 14, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Witty, G1 Therapeutics, GSK, biotech, drugs, pharma, pharmaceutical
Only a short while after leaving his position as CEO of GSK, it seems Andrew Witty cannot resist getting back …
What Brexit means for drug regulation
July 14, 2017Medical Communications, Sales and Marketing biotech, brexit, drugs, healthcare, pharma, pharmaceuticals, regulation
The pharmaceutical sector is one of the most tightly regulated industries, and most of the rules that govern the daily …
Independent panel advise FDA to apply different framework to opioid painkillers
July 14, 2017Medical Communications FDA, biotech, drugs, opioid, opioid epidemic, pharma, pharmaceutical
Over a year ago, the Obama administration asked the National Academies of Sciences, Engineering, and Medicine to advise them on …
FDA unanimously recommends Mylan and Biocon’s Herceptin biosimilar
July 14, 2017Manufacturing and Production, Medical Communications, Sales and Marketing Biocon, Herceptin, Mylan, biosimilar, biotech, drugs, healthcare, life sciences, pharma, pharmaceuticals
Mylan and Biocon have revealed that their biosimilar version of Roche and Genentech’s Herceptin (trastuzumab) has received unanimous recommendation from …
Top Ten most popular articles on Pharmafile.com this week
July 14, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, life sciences, pharma, pharmaceutical, top ten
As the week comes to a close, we bring you the stories that were most read by our readers – …
J&J uses FDA Priority Review Voucher to snag psoriasis approval
July 14, 2017Medical Communications, Sales and Marketing Janssen, Johnson & Johnson, Tremfya, biotech, drugs, pharma, pharmaceutical
The FDA has handed out another approval, as the agency now easily surpasses last year’s figure of 22 already, this …
Latest content
Five Facts about cardiovascular disease
Artificial hearts: a century of innovation
